1Yanagisawa M, Kafihara H, Kimura S, et al. A novel potevasoconstrictor peptide produced by vascular endothelial cell [ J ]. Nature, 1998, 322(31 ) :411 -415.
2Bagnato A, Natali PG. Endotheline receptor as novel targets in tumor therapy[J]. J Transl Med,2004,2( 1 ) :16.
3Vacca F, Bagnato A , Catt K J, et al. Transctivation of the epidermal growth factor receptor in endothelin - 1 - induced mitogenic signaling in human ovarian carcinoma cells [ J]. Cancer Res, 2000,60 ( 18 ) : 5310 -5317.
4Wu - Wong JR, Chiou WJ, Wang J. Extracellular signal - regnlatedkinases are involved in the antiapoptotie effect of endothelin -1 [ J] . J Pharmacol Exp Ther, 2000, 29 3(2 ) :514 -521.
5Del Bufalo D, Di Castro V, Biroccio A, et al. Endothlin - 1 protects ovarian cells against paclitaxel -induced apoptosis: requirement for akt activation[ J ]. Mol Pharmacol,2002,61 ( 3 ) :524 - 532.
6Codara C, Cannon GW, Gannon GM, et al. Role of endothel Axis in progression to aggressive phenotype of prostate adenocarcinoma [ J ]. Prostate, 2005,65( 1 ) :27 -34.
7Di Gastro V. Inhibition of cyclouaygeaaee - 1 and - 2 expression by targeting the endothelia a receptor in human ovarion carcinoma cells [ J]. Cbn Cancer Res, 2004, 10(14) :4670 -4679.
8Nelson JB,Udan MS,Guruli G, et al. Endothetin -1 inhibits Apoptosis in prostate cancer [ J ]. Neoplasia, 2005, 7 (7) :631 - 637.
9Kamrava M, Simpkins F, Alejandro E, et al. Lysophosphatidic acid and endothel in - induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin epithelin precursor(GEP), a pmsurvival factor for ovarian cancer [ J ]. Oncogene, 2005,24 (47) : 7084 - 7093.
10Salani D, Di castro V, Nicitra MR, et al. Role of Endothelin in neovascu- larization of ovarian carcinoma[J]. Am J Pathol, 2000, 157(5) :1537 -1547.
